We utilized the GWAS catalog database to identify potential genetic associations with Alzheimer’s disease and/or dementia linked to the 47 common genes present between associated proteins of EVOO and targets of NRF2 activators in ongoing clinical trials. This evidence concerns the gene NFE2L2 and Alzheimer disease.